Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 144,873	$ 190,505
Restricted cash, current	536	2,830
Accounts receivable, net	34,463	31,730
Inventory	119,532	130,336
Prepaid expenses and other current assets	15,538	12,904
Assets held for sale	2,323	4,539
Total current assets	317,265	372,844
Restricted cash, non-current	12,600	12,600
Property, plant, and equipment, net	186,584	194,046
Operating lease right-of-use assets	127,679	130,460
Prepaid lease costs, non-current	64,822	61,635
Other non-current assets, net	634	1,192
Investment in unconsolidated joint venture	1,650	1,673
Total assets	711,234	774,450
Current liabilities:
Accounts payable	59,449	56,032
Accrued bonus	393	4,790
Current portion of operating lease liabilities	4,125	3,677
Accrued litigation settlement costs	7,500	0
Accrued expenses and other current liabilities	12,051	9,855
Total current liabilities	83,518	74,354
Long-term liabilities:
Convertible senior notes, net	1,139,509	1,137,542
Operating lease liabilities, net of current portion	74,884	75,648
Finance lease obligations and other long-term liabilities	3,348	274
Total long-term liabilities	1,217,741	1,213,464
Commitments and Contingencies (Note 9)
Stockholders’ deficit:
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding	0	0
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 64,993,318 and 64,624,140 shares issued and outstanding at June 29, 2024 and December 31, 2023, respectively	6	6
Additional paid-in capital	584,441	573,128
Accumulated deficit	(1,170,093)	(1,081,253)
Accumulated other comprehensive loss	(4,379)	(5,249)
Total stockholders’ deficit	(590,025)	(513,368)
Total liabilities and stockholders’ deficit	$ 711,234	$ 774,450